Mackay Shields LLC Repligen Corp Transaction History

Mackay Shields LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$122.51 - $158.27 $759,562 - $981,274	-6,200 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$94.33 - $140.48 $1.5 Million - $2.23 Million	-15,900 Reduced 71.95%	6,200 $766,000
Q1 2020 May 08, 2020	BUY	$84.96 - $109.14 $1.17 Million - $1.51 Million	13,799 Added 166.23%	22,100 $2.13 Million
Q4 2019 Feb 11, 2020	SELL	$73.84 - $93.08 $2.1 Million - $2.64 Million	-28,410 Reduced 77.39%	8,301 $768,000
Q3 2019 Nov 01, 2019	SELL	$76.65 - $95.51 $199,290 - $248,326	-2,600 Reduced 6.61%	36,711 $2.82 Million
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $1.19 Million - $1.89 Million	22,037 Added 127.57%	39,311 $3.38 Million
Q1 2019 May 13, 2019	SELL	$49.45 - $62.8 $74,175 - $94,200	-1,500 Reduced 7.99%	17,274 $1.02 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $392,450 - $560,132	-8,132 Reduced 30.22%	18,774 $990,000
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $318,240 - $400,996	6,800 Added 33.82%	26,906 $1.49 Million
Q2 2018 Aug 06, 2018	SELL	$35.26 - $47.04 $21,156 - $28,224	-600 Reduced 2.9%	20,106 $946,000
Q1 2018 May 03, 2018	BUY	$30.92 - $37.27 $640,229 - $771,712	20,706 New	20,706 $749,000

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.18B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.